Kura Oncology (KURA) Earnings Date & Reports

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

KURA is expected to report earnings to rise 16.12% to -89 cents per share on October 29

Kura Oncology KURA Stock Earnings Reports

Q3'26

Est.

$-0.89

Q2'26

Beat

by $0.11

Q1'26

Est.

$-0.83

Q4'25

Missed

by $0.66

Q3'25

Missed

by $0.10

The last earnings report on August 12 showed earnings per share of -76 cents, beating the estimate of -87 cents. With 940.64K shares outstanding, the current market capitalization sits at 966.11M.

View a ticker or compare two or three

KURA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days